← Back to catalogue

Aldurazyme 2.9 Mg/5ml Medsu Vl1 Diag Us

FDA UDI

Class I (US FDA UDI)

by Genzyme Corp.

Identity

Trade Name
ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US FDA UDI
Generic Name
Assay development analyte-specific reagent IVD FDA UDI
Device Name
ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US FDA UDI
Model / Reference
762618 FDA UDI
Description
ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US FDA UDI

Identifiers

Primary DI / UDI-DI
00358468000019 FDA UDI
FDA Product Code
MVU FDA UDI
GMDN Term
Assay development analyte-specific reagent IVD FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.4020 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Assay development analyte-specific reagent IVD

The ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US device is a specific antibody-based analyte-specific reagent for the development of laboratory-developed tests (LDTs) or commercial in vitro diagnostic medical devices (IVDs). It is not labelled with instructions for use, diagnostic claims, or performance information. As an assay development analyte-specific reagent IVD, it is used to identify or quantify chemicals in biological specimens.

Similar devices

Also classified as Assay development analyte-specific reagent IVD.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Genzyme Corp.

Sources (1)

  • FDA UDI c4c090de-d4f6-4eb5-9485-fa143125f06b 33 fields · synced Jul 19, 2026